Oslo University Hospital
1,183
177
302
601
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.1%
60 terminated/withdrawn out of 1183 trials
90.9%
+4.4% vs industry average
12%
137 trials in Phase 3/4
4%
24 of 601 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1183)
Change in Cognition and Frailty After Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus (iNPH)
Role: lead
Elastography-based Brief Alcohol Intervention in Hospitalized Individuals
Role: lead
AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
Role: lead
Diagnostic Performance of Low-Dose CT for Acute Abdominal Conditions
Role: lead
Acetated Ringer´s Solution in Experimental Hypovolemia
Role: lead
MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis
Role: lead
Return to Cross Country Skiing and Other Physical Activities After Arthrodesis of the First Metatarsophalangeal Joint
Role: lead
De-labeling of Patients With False Diagnosis of Penicillin Allergy
Role: lead
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Role: lead
Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity
Role: lead
GENicular Nerve Block in KNEE Arthroplasty
Role: collaborator
Proton Versus Photon Therapy in Head and Neck Squamous Cell Carcinomas.
Role: lead
Free Fluid Detection With Telementored eFAST
Role: lead
A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients
Role: lead
Nurse-led Smoking Cessation Program With Follow-up in Healthy Life Centres: a Randomized Clinical Trial
Role: collaborator
A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries
Role: collaborator
Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to Reduce Pain and Improve Physical Function.
Role: lead
Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)
Role: collaborator
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial
Role: collaborator
Two-week Intensive Outpatient Trauma Treatment.
Role: lead